Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Biolase granted extension to regain compliance with NASDAQ listing rules » 16:22
11/23/21
11/23
16:22
11/23/21
16:22
BIOL

Biolase

/

+

BIOLASE announced its…

BIOLASE announced its receipt of written notification from the Listing Qualification Department of The NASDAQ Stock Market granting BIOLASE's request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550. BIOLASE now has until May 23, 2022 to regain compliance with the Bid Price Rule. Nasdaq's extension notice has no immediate effect on the continued listing status of BIOLASE's common stock, which remains listed on The NASDAQ Capital Market. If at any time until May 23, 2022, the bid price for BIOLASE's common stock closes at or above $1.00 per share for a minimum of 10 consecutive trading days, BIOLASE will regain compliance with the Bid Price Rule, and the matter will be closed.

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
BIOL Biolase
/

+

BIOL Biolase
/

+

Hot Stocks
Biolase issues recommendation to stockholders in favor of reverse stock split » 16:24
11/17/21
11/17
16:24
11/17/21
16:24
BIOL

Biolase

/

+

Biolase issued a…

Biolase issued a statement encouraging stockholders to vote in favor of the amendment to the Biolase Certificate of Incorporation to effect a reverse stock split - without reducing the authorized number of shares of common stock -. The special meeting of Biolase stockholders is scheduled to be held on November 19. The reverse stock split will not affect stockholders' percentage ownership of Biolase. The company's Board stated that approving the amendment will: "Help ensure continued listing of our common stock on The Nasdaq Capital Market, Attract institutional investors and promote greater liquidity for our stockholders, Enable us to offer equity compensation to employees and other service providers (and, thus, conserve cash), and Provide that shares of common stock are authorized and available for future uses". The company also stated that Proxy advisory firms ISS and Glass Lewis have recommended that stockholders vote in favor of the reverse stock split.

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
BIOL Biolase
/

+

BIOL Biolase
/

+

Earnings
Biolase sees Q4 revenue above $10.62M, consensus $10.2M  16:29
11/10/21
11/10
16:29
11/10/21
16:29
BIOL

Biolase

/

+

 
ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
BIOL Biolase
/

+

BIOL Biolase
/

+

Earnings
Biolase reports Q3 EPS (2c), consensus (3c) » 16:29
11/10/21
11/10
16:29
11/10/21
16:29
BIOL

Biolase

/

+

Reports Q3 revenue $9.5M,…

Reports Q3 revenue $9.5M, consensus $8.78M. "Our strong Q3 performance continues to reflect the rising demand for our industry-leading dental lasers," commented CEO John Beaver. "Our efforts to both educate and train dental specialists is leading to increased adoption across these large and largely untapped markets. In today's environment, the fact that BIOLASE lasers provide increased safety to dentists and their patients is generating a high level of acceptance by dental practitioners - and we expect this to be a driving force for the foreseeable future. Our industry-leading dental lasers aim to provide a better standard of care for dental procedures and seek to ensure a safer experience while reducing the risk of future procedure and business disruptions by reducing aerosolization to mitigate the spread of infectious pathogens, such as COVID-19. Looking ahead, we expect significant year-over-year improvement across our key performance metrics, including revenue and gross margin in the fourth quarter as we continue to gain momentum with new customers and dental specialists."

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
BIOL Biolase
/

+

BIOL Biolase
/

+

Over a month ago
Conference/Events
Biolase to hold a Q&A webcast » 15:45
10/25/21
10/25
15:45
10/25/21
15:45
BIOL

Biolase

/

+

In conjunction with the…

In conjunction with the upcoming Special Shareholder Meeting, Management holds a Q&A webcast on October 25 at 4 pm. Webcast Link

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
BIOL Biolase
/

+

BIOL Biolase
/

+

Conference/Events
Biolase to hold a Q&A webcast » 04:55
10/25/21
10/25
04:55
10/25/21
04:55
BIOL

Biolase

/

+

In conjunction with the…

In conjunction with the upcoming Special Shareholder Meeting, Management holds a Q&A webcast on October 25 at 4 pm. Webcast Link

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
BIOL Biolase
/

+

BIOL Biolase
/

+

Conference/Events
Biolase to hold a Q&A webcast » 15:35
10/21/21
10/21
15:35
10/21/21
15:35
BIOL

Biolase

/

+

In conjunction with the…

In conjunction with the upcoming Special Shareholder Meeting, Management holds a Q&A webcast on October 25 at 4 pm. Webcast Link

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
BIOL Biolase
/

+

BIOL Biolase
/

+

Over a quarter ago
Recommendations
Biolase price target raised to $3 from $2 at Ascendiant » 05:58
08/19/21
08/19
05:58
08/19/21
05:58
BIOL

Biolase

/

+

Ascendiant analyst Edward…

Ascendiant analyst Edward Woo raised the firm's price target on Biolase to $3 from $2 and keeps a Buy rating on the shares. The analyst remains positive on the company's long-term growth potential post the Q2 results.

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
10/14/20 Maxim
Biolase initiated with a Buy at Maxim
BIOL Biolase
/

+

BIOL Biolase
/

+

Earnings
Biolase sees Q3 revenue 'significantly above' year-ago quarter » 09:16
08/13/21
08/13
09:16
08/13/21
09:16
BIOL

Biolase

/

+

Along with its earnings…

Along with its earnings report last night, Biolase stated: "The company continues to experience high demand for its dental lasers and is currently forecasting revenue for the third quarter ending September 30, 2021, to be significantly above the year-ago third quarter despite the pent up demand the company experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter. Even though the third quarter of the year is seasonally our second weakest revenue quarter, we expect the third quarter of 2021 to approach revenues we achieved in the second quarter of 2021." In pre-market trading, Biolase shares are up 31c, or 49%, to 94c.

ShowHide Related Items >><<
BIOL Biolase
/

+

BIOL Biolase
/

+

01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
10/14/20 Maxim
Biolase initiated with a Buy at Maxim
BIOL Biolase
/

+

BIOL Biolase
/

+

On The Fly
Fly Intel: Pre-market Movers » 08:55
08/13/21
08/13
08:55
08/13/21
08:55
DIS

Disney

$179.35 /

+1.27 (+0.71%)

, BIOL

Biolase

/

+

, RKT

Rocket Companies

$17.48 /

-0.135 (-0.77%)

, ZIP

ZipRecruiter

$29.18 /

+0.48 (+1.67%)

, WISH

ContextLogic

$9.40 /

-0.42 (-4.28%)

, ABNB

Airbnb

$151.00 /

+2.83 (+1.91%)

, DASH

DoorDash

$188.23 /

-1.83 (-0.96%)

, CRCT

Cricut

$34.45 /

+0.945 (+2.82%)

, TTCF

Tattooed Chef

$20.34 /

-0.465 (-2.24%)

, PPC

Pilgrim's Pride

$22.68 /

-0.38 (-1.65%)

Check out this morning's…

ShowHide Related Items >><<
ZIP ZipRecruiter
$29.18 /

+0.48 (+1.67%)

WISH ContextLogic
$9.40 /

-0.42 (-4.28%)

TTCF Tattooed Chef
$20.34 /

-0.465 (-2.24%)

RKT Rocket Companies
$17.48 /

-0.135 (-0.77%)

PPC Pilgrim's Pride
$22.68 /

-0.38 (-1.65%)

DIS Disney
$179.35 /

+1.27 (+0.71%)

DASH DoorDash
$188.23 /

-1.83 (-0.96%)

CRCT Cricut
$34.45 /

+0.945 (+2.82%)

BIOL Biolase
/

+

ABNB Airbnb
$151.00 /

+2.83 (+1.91%)

DIS Disney
$179.35 /

+1.27 (+0.71%)

08/13/21 Goldman Sachs
Disney price target raised to $218 from $215 at Goldman Sachs
08/13/21 BMO Capital
Disney price target raised to $195 from $190 at BMO Capital
07/14/21 Tigress Financial
Disney shares can hit $227 within 12 months, says Tigress Financial
07/13/21 KeyBanc
D2C video services best positioned to capture industry economics, says KeyBanc
BIOL Biolase
/

+

01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
10/14/20 Maxim
Biolase initiated with a Buy at Maxim
RKT Rocket Companies
$17.48 /

-0.135 (-0.77%)

08/13/21 Piper Sandler
Rocket Companies price target raised to $20 from $18 at Piper Sandler
08/13/21 Morgan Stanley
Rocket Companies price target raised to $19 from $18 at Morgan Stanley
07/20/21 Wedbush
Rocket Companies downgraded to Underperform at Wedbush
07/20/21 Wedbush
Rocket Companies downgraded to Underperform from Neutral at Wedbush
ZIP ZipRecruiter
$29.18 /

+0.48 (+1.67%)

08/13/21 Raymond James
ZipRecruiter price target raised to $40 from $36 at Raymond James
07/01/21 Barclays
ZipRecruiter initiated with an Overweight at Barclays
06/21/21
Fly Intel: Top five analyst initiations
06/21/21 JPMorgan
ZipRecruiter initiated with a Neutral at JPMorgan
WISH ContextLogic
$9.40 /

-0.42 (-4.28%)

08/13/21 Loop Capital
ContextLogic price target lowered to $15 from $20 at Loop Capital
08/13/21 Oppenheimer
ContextLogic downgraded to Perform from Outperform at Oppenheimer
08/13/21 William Blair
ContextLogic downgraded to Market Perform from Outperform at William Blair
08/13/21 Oppenheimer
ContextLogic downgraded to Perform from Outperform at Oppenheimer
ABNB Airbnb
$151.00 /

+2.83 (+1.91%)

08/13/21 Needham
Airbnb price target raised to $200 from $194 at Needham
08/13/21 Wells Fargo
Airbnb price target raised to $210 from $200 at Wells Fargo
08/13/21 JMP Securities
Airbnb price target lowered to $180 from $190 at JMP Securities
08/03/21
Fly Intel: Top five analyst upgrades
DASH DoorDash
$188.23 /

-1.83 (-0.96%)

08/13/21 JPMorgan
DoorDash price target raised to $186 from $160 at JPMorgan
08/13/21 RBC Capital
DoorDash price target raised to $210 from $175 at RBC Capital
08/13/21 Needham
DoorDash price target raised to $230 from $195 at Needham
08/13/21 Wells Fargo
DoorDash price target raised to $235 from $215 at Wells Fargo
CRCT Cricut
$34.45 /

+0.945 (+2.82%)

08/13/21 Goldman Sachs
Cricut downgraded to Neutral from Buy at Goldman Sachs
08/13/21 Morgan Stanley
Cricut downgraded to Underweight from Equal Weight at Morgan Stanley
08/13/21 Morgan Stanley
Cricut downgraded to Underweight from Equal Weight at Morgan Stanley
06/10/21 Morgan Stanley
Cricut downgraded to Equal Weight from Overweight at Morgan Stanley
TTCF Tattooed Chef
$20.34 /

-0.465 (-2.24%)

06/11/21
Tattooed Chef management to meet virtually with Roth Capital
12/03/20 Jefferies
Tattooed Chef initiated with a Hold at Jefferies
11/17/20 Roth Capital
Tattooed Chef initiated with a Buy at Roth Capital
PPC Pilgrim's Pride
$22.68 /

-0.38 (-1.65%)

06/03/21 Barclays
Pilgrim's Pride price target raised to $28 from $25 at Barclays
04/30/21 BMO Capital
Pilgrim's Pride price target raised to $28 from $21 at BMO Capital
04/09/21 Stephens
Tyson Foods price target raised to $90 from $80 at Stephens
02/08/21 Stephens
Pilgrim's Pride upgraded to Overweight on improving chicken view at Stephens
ZIP ZipRecruiter
$29.18 /

+0.48 (+1.67%)

WISH ContextLogic
$9.40 /

-0.42 (-4.28%)

TTCF Tattooed Chef
$20.34 /

-0.465 (-2.24%)

RKT Rocket Companies
$17.48 /

-0.135 (-0.77%)

PPC Pilgrim's Pride
$22.68 /

-0.38 (-1.65%)

DIS Disney
$179.35 /

+1.27 (+0.71%)

DASH DoorDash
$188.23 /

-1.83 (-0.96%)

CRCT Cricut
$34.45 /

+0.945 (+2.82%)

BIOL Biolase
/

+

ABNB Airbnb
$151.00 /

+2.83 (+1.91%)

  • 20
    May
  • 26
    May
  • 25
    Mar
  • 16
    Dec
  • 10
    Dec
  • 09
    Dec
WISH ContextLogic
$9.40 /

-0.42 (-4.28%)

RKT Rocket Companies
$17.48 /

-0.135 (-0.77%)

PPC Pilgrim's Pride
$22.68 /

-0.38 (-1.65%)

DIS Disney
$179.35 /

+1.27 (+0.71%)

DASH DoorDash
$188.23 /

-1.83 (-0.96%)

ABNB Airbnb
$151.00 /

+2.83 (+1.91%)

ZIP ZipRecruiter
$29.18 /

+0.48 (+1.67%)

WISH ContextLogic
$9.40 /

-0.42 (-4.28%)

TTCF Tattooed Chef
$20.34 /

-0.465 (-2.24%)

RKT Rocket Companies
$17.48 /

-0.135 (-0.77%)

PPC Pilgrim's Pride
$22.68 /

-0.38 (-1.65%)

DIS Disney
$179.35 /

+1.27 (+0.71%)

DASH DoorDash
$188.23 /

-1.83 (-0.96%)

CRCT Cricut
$34.45 /

+0.945 (+2.82%)

ABNB Airbnb
$151.00 /

+2.83 (+1.91%)

ZIP ZipRecruiter
$29.18 /

+0.48 (+1.67%)

WISH ContextLogic
$9.40 /

-0.42 (-4.28%)

TTCF Tattooed Chef
$20.34 /

-0.465 (-2.24%)

RKT Rocket Companies
$17.48 /

-0.135 (-0.77%)

DIS Disney
$179.35 /

+1.27 (+0.71%)

DASH DoorDash
$188.23 /

-1.83 (-0.96%)

CRCT Cricut
$34.45 /

+0.945 (+2.82%)

ABNB Airbnb
$151.00 /

+2.83 (+1.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.